Trademarkia Logo

Australia

AU$
DISRUPTING DISEASE
Published: Under examination

Last updated on 3 Aug 2024

Owner Info

Alnylam Pharmaceuticals, Inc.

675 West Kendall Street

Cambridge MA 02142, UNITED STATES OF AMERICA

Serial Number

2470740 filed on 3 Jul 2024

Correspondent

Jennifer Kwon Womble Bond Dickinson (US) LLP

950 Third Avenue, Suite 2400,

New York NY 10022,

UNITED STATES OF AMERICA

DISRUPTING DISEASE

Classification Information


Class [042]
Scientific research; scientific research in the fields of pharmaceuticals and medicine, chemical and medical laboratories; providing scientific inform Read More

Mark Details


Serial Number

2470740

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

19 Jun 2024

Mark Type

US

Legal History


Show more

Status DateAction Taken
3rd Aug 2024Adverse Report (Examination) correspondence sent
2th Aug 2024IP Right has been Examined
1st Aug 2024Awaiting examination
1st Aug 2024Examination expedited
1st Aug 2024IP Right Filed Published
1st Aug 2024Status change to Published
1st Aug 2024Status change to Filed
1st Aug 2024Application Received
1st Aug 2024IP right goods and service classes updated
1st Aug 2024IP Right Goods and Services Items updated